X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs NATCO PHARMA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD NATCO PHARMA WYETH LTD/
NATCO PHARMA
 
P/E (TTM) x 27.7 13.9 199.7% View Chart
P/BV x 5.3 4.0 134.7% View Chart
Dividend Yield % 1.3 1.1 113.5%  

Financials

 WYETH LTD   NATCO PHARMA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
NATCO PHARMA
Mar-18
WYETH LTD/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0441,080 96.7%   
Low Rs818671 121.9%   
Sales per share (Unadj.) Rs298.6592.1 50.4%  
Earnings per share (Unadj.) Rs57.2188.4 30.4%  
Cash flow per share (Unadj.) Rs58.4206.3 28.3%  
Dividends per share (Unadj.) Rs17.008.25 206.1%  
Dividend yield (eoy) %1.80.9 193.8%  
Book value per share (Unadj.) Rs249.5833.6 29.9%  
Shares outstanding (eoy) m22.7236.90 61.6%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x3.11.5 210.9%   
Avg P/E ratio x16.34.6 350.0%  
P/CF ratio (eoy) x15.94.2 375.7%  
Price / Book Value ratio x3.71.1 355.3%  
Dividend payout %29.74.4 678.2%   
Avg Mkt Cap Rs m21,15732,311 65.5%   
No. of employees `0000.54.8 10.2%   
Total wages/salary Rs m4003,256 12.3%   
Avg. sales/employee Rs Th13,787.44,522.5 304.9%   
Avg. wages/employee Rs Th813.0674.0 120.6%   
Avg. net profit/employee Rs Th2,643.31,439.0 183.7%   
INCOME DATA
Net Sales Rs m6,78321,848 31.0%  
Other income Rs m353404 87.3%   
Total revenues Rs m7,13622,252 32.1%   
Gross profit Rs m1,6179,284 17.4%  
Depreciation Rs m27662 4.0%   
Interest Rs m6154 3.6%   
Profit before tax Rs m1,9388,872 21.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6321,920 32.9%   
Profit after tax Rs m1,3016,952 18.7%  
Gross profit margin %23.842.5 56.1%  
Effective tax rate %32.621.6 150.8%   
Net profit margin %19.231.8 60.3%  
BALANCE SHEET DATA
Current assets Rs m6,98421,307 32.8%   
Current liabilities Rs m2,0565,920 34.7%   
Net working cap to sales %72.670.4 103.2%  
Current ratio x3.43.6 94.4%  
Inventory Days Days9973 135.5%  
Debtors Days Days24107 22.5%  
Net fixed assets Rs m24414,986 1.6%   
Share capital Rs m227369 61.6%   
"Free" reserves Rs m5,44130,353 17.9%   
Net worth Rs m5,66830,760 18.4%   
Long term debt Rs m250-   
Total assets Rs m7,90137,151 21.3%  
Interest coverage x353.358.6 602.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.6 146.0%   
Return on assets %16.519.1 86.4%  
Return on equity %22.922.6 101.5%  
Return on capital %34.029.3 116.0%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m1510,322 0.1%   
Fx outflow Rs m2,6772,978 89.9%   
Net fx Rs m-2,6627,343 -36.3%   
CASH FLOW
From Operations Rs m9234,636 19.9%  
From Investments Rs m317-11,155 -2.8%  
From Financial Activity Rs m-4816,509 -7.4%  
Net Cashflow Rs m759-18 -4,217.2%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 51.1 1.5 3,476.2%  
Indian inst/Mut Fund % 11.3 7.8 144.1%  
FIIs % 7.2 16.6 43.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 26.0 116.9%  
Shareholders   21,978 25,395 86.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  CADILA HEALTHCARE  GSK PHARMA  PANACEA BIOTECH  

Compare WYETH LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Macroeconomic Cues Guide the Markets This Week(Podcast)

Global markets remained in pressure this week. Pound fell sharply as risk of chaotic Brexit rose.

Related Views on News

NATCO PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 115.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 115.2% YoY). Sales on the other hand came in at Rs 5 bn (up 27.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 93.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 93.3% YoY). Sales on the other hand came in at Rs 5 bn (up 21.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - PFIZER COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS